Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques in Pregnant Females

Not Applicable

Recruiting

• Conditions: Meralgia Paresthetica

• Registration Number: NCT06751147
• Lead Sponsor: Riphah International University

Brief Summary

The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity

Detailed Description

The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of lateral femoral cutaneous nerve mobilization in combination with MET in pregnant females. Secondly no quantitative measurement as range of motion with goniometer has been yet studied

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2023-12-23
• Status Verified: 2024-12
• Study First Submitted: 2024-12-20
• Study First Submitted QC: 2024-12-20
• Last Update Submitted: 2024-12-20
• Study First Posted: 2024-12-27
• Last Update Posted: 2024-12-27
• Primary Completion: 2025-02
• Study Completion: 2025-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 48

Inclusion Criteria

• Age ranges from 18 to 40 years
• Body mass index ≥25kg/m2.
• Pregnant females in third trimester diagnosed with myalgia paraesthetica.
• Multigravida pregnant females
• Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
• Positive pelvic compression test(1)

Read More

Exclusion Criteria

• Those having other entrapment syndromes or radicular symptoms
• Motor weakness
• Having a history or ongoing cancerous proliferation
• Active infection

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
quality of life is assessed by QOL questioner	at base line pre intervention, at the end of 4th week post intervention	EQ-5D is used to measure quality of life
Knee range of motion is used to measure ROM	at base line pre intervention, at the end of 4th week post intervention	measured by goniometer
neuropathic pain	at base line pre intervention, at the end of 4th week post intervention	measured by neuropathic pain scale

Trial Locations

Locations (2)

Ghurkhi Hospital; 🇵🇰 Lahore, Punjab, Pakistan

Ghurki Hospital; 🇵🇰 Lahore, Punjab, Pakistan